0001615774-18-003426.txt : 20180507 0001615774-18-003426.hdr.sgml : 20180507 20180507214825 ACCESSION NUMBER: 0001615774-18-003426 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180503 FILED AS OF DATE: 20180507 DATE AS OF CHANGE: 20180507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Gregg CENTRAL INDEX KEY: 0001624919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36747 FILM NUMBER: 18812803 MAIL ADDRESS: STREET 1: PO BOX 200 CITY: WALLED LAKE STATE: MI ZIP: 48390-0200 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001266806 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 BUSINESS PHONE: 818-833-5000 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 4 1 s110028_form4.xml 4 X0306 4 2018-05-03 0 0001266806 SECOND SIGHT MEDICAL PRODUCTS INC EYES 0001624919 Williams Gregg 12744 SAN FERNANDO ROAD, SUITE 400 SYLMAR CA 91342 1 0 1 0 COMMON STOCK 2018-05-03 4 P 0 4729730 1.48 A 24212302 I See footnote COMMON STOCK 2018-05-03 4 P 0 2027027 1.48 A 26239329 I See footnote Sam B Williams 95 GST Trust ("GST") acquired 4,729,730 shares of common stock in a private placement pursuant to a Securities Purchase Agreement ("SPA") on May 3, 2018 from the issuer at a purchase price of $1.48 per share, the last reported sale price by Nasdaq on May 3, 2018. Mr. Williams is a trustee of GST. Gregg G. Williams 2006 Trust ("GW") acquired 2,027,027 shares of common stock in a private placement pursuant to the SPA on May 3, 2018 from the issuer of a purchase price of $1.48 per share, the last reported sale price by NASDAQ on May 3, 2018. Mr. Williams is a trustee of GW Trust. After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 15,625,639 shares of common stock and warrants to purchase 6,802,721 shares of common stock owned by GW Trust, (ii) 1,484,254 shares of common stock owned by Williams International Co. LLC, whose manager is Mr. Williams, (iii) 4,358,082 shares of common stock owned by Sam Williams Family Investments LLC, whose manager is Mr. Williams, and (iv) 4,771,354 shares of common stock owned by GST. /s/ John T. Blake by Power-of-Attorney 2018-05-07 EX-24.1 2 s110028_ex24-1.htm EXHIBIT 24.1

Exhibit 24.1

POWER OF ATTORNEY

(FOR EXECUTING FORM ID, FORMS 3, 4 AND 5 AND SCHEDULES 13D AND 13G)

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints John Blake and Scott Dunbar, or either of them, signing individually, the undersigned’s true and lawful attorneys-in-fact and agents to:

(i) prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the Securities and Exchange Commission of reports required by Section 13(d) and Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or any rules or regulations promulgated thereunder;

(ii) prepare, execute and file, for and on behalf of the undersigned with respect to holdings of and transactions in securities issued by a company to the undersigned or Second Sight Medical Products, Inc. any and all documents and filings that are required or advisable to be made with the United States Securities and Exchange Commission, any stock exchange or similar authority, under the Exchange Act, including without limitation (a) any Joint Filing Agreement under Rule 13d-1(k) of the Exchange Act (or any successor provision thereunder), Schedule 13D and Schedule 13G (or any successor schedules or forms adopted under the Exchange Act) and any amendments thereto in accordance with Section 13 of the Exchange Act and the rules thereunder, and (b) Forms 3, 4 and 5 and any amendments thereto in accordance with Section 16(a) of the Exchange Act and the rules thereunder; and

(iii) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact in serving in such capacity at the request of the undersigned, are not assuming, nor is Second Sight Medical Products, Inc. assuming, any of the undersigned’s responsibilities to comply with the Exchange Act, including without limitation Sections 13 and 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file any form or document with respect to the undersigned’s holdings of and transactions in securities issued by a company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact shall no longer be employed by (or ceases to be a Director of) Second Sight Medical Products, Inc.

I hereby declare that any act or thing lawfully done hereunder by the foregoing attorneys-in-fact shall be binding on the undersigned as if done by myself.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 27^th day of March, 2018.

/s/ Gregg Williams

Gregg Williams